Merz Pharma GmbH & Co. KGaA is an innovative and international healthcare company with its own research and development department. It focuses on drugs for the treatment of illness in the fields of neurology and psychiatry. The company is bundling the activities of its subsidiaries Merz Pharmaceuticals, Merz Consumer Care, Merz Dental, and Merz Hygiene, with products ranging from prescription drugs and OTC products for health and wellness, materials for dentists and dental technicians to hygienic products for medical disinfection and cleaning.\nThe units of Merz Group Services, the fith Merz subsidiary, include Human Resources, Supply Chain/Purchasing, Information Technology (IT), Technical Operations and Finances/Controlling.

Emulate, Inc. owns and operates Organs-on-Chips platform which acts as an automated human bioemulation platform for mimicking true human physiology. The firm's product responses to medicines, chemicals, and diseases can be predicted. The company was founded by James Coon, Donald Ingber and Geraldine Hamilton in July 2014 and is headquartered in Cambridge, MA.

Peking Union Medical College Hospital, also known as Beijing Xiehe Hospital (Chinese: 北京协和医院), is a renowned general hospital in Beijing, China. It was founded in 1921 by Rockefeller Foundation and is affiliated to both Peking Union Medical College (PUMC) and Chinese Academy of Medical Sciences (CAMS). During the Cultural Revolution, it was renamed the "Anti-imperialist Hospital".

IntelliCyt Corporation develops and markets innovative high-throughput cell and bead-based screening solutions for use throughout the life sciences. The Company uses proprietary technologies to create instrumentation, reagent kits, and software products that dramatically increase the speed and decrease the cost of detecting and measuring cells and beads. IntelliCyt’s products address a pervasive need among pharmaceutical, biotechnology, and life science research laboratories to achieve increased productivity while adapting to the accelerating pace and increasing complexity of modern life sciences. Founded in 2006 by life science entrepreneurs and leading scientists, IntelliCyt Corporation was the first to commercialize a true high throughput screening platform for suspension cells that addresses urgent unmet needs in phenotypic small molecule drug discovery, antibody discovery, in vitro toxicology as well as other high profile research areas. By combining the sensitive, proven detection technology of flow cytometry with a patented sample processing technology, IntelliCyt’s HTFC Screening System enables suspension cell assays at speeds up to 40x faster than traditional flow cytometry. IntelliCyt has integrated HTFC with application-specific reagent kits and informatics software to address the growing market for high throughput cell based assays to provide earlier, more physiologically relevant results at lower cost.

Bioneer is a biotech company that develops molecular biology products and technologies including oligonucleotides, thermostable polymerases, and instruments of gene manipulation. From its inception, Bioneer has invested in the integration of recombinant DNA technology, fermentation, biochemistry and nucleic acid chemistry in addition to mechanics, photonics and electronics. The company is positioned to fully-integrate its capability to develop next-generation technologies in the post-genome era through the invention of new biochemistry and instruments. Bioneer was established in 1992 and is based in Daejeon, South Korea.

ViroCyt focuses on the commercialization of novel technologies that enable the rapid quantification of viruses. Our goal is to provide the tools that deliver meaningful improvements to mission-critical processes, such as vaccine manufacturing, protein expression, antiviral development, and other settings where viruses play a significant role. It was founded in 2012 and is based in Broomfield, Colorado.

Bioneer is a Danish advanced technology company, providing custom development- and analytical services to projects in drug development- and diagnostic companies, academic groups and hospitals. Bioneer is highly specialized within applications of cells, using their extensive knowledge anywhere from disease modeling using pluripotent stem cells and human primary cells; to recombinant protein production and biomarker identification/validation (RNA, DNA, protein) in single-cell- and tissue preparations. Furthermore, Bioneer also offers drug development of small molecules and biologics, from characterization through to a final formulation.

Multi Sciences (Lianke) Biotech Co., Ltd. (doing business as Hangzhou Lianke Biotechnology Co., Ltd.) is a Chinese private company located in Hangzhou that manufactures pharmaceutical preparations.

Genome Wisdom is a gene-based precision medical technology service provider that provides high-throughput, high-precision genomic data solutions for clinical & personal genomes, including disease molecular mechanisms based on multi-omics integration analysis, and oncology treatment dynamics. Design, implementation and industrial incubation of scientific research projects such as surveillance and tumor space molecular pathology analysis.

antibodies-online GmbH provides a marketplace for product research. Its products include Antibodies and Secondary Antibodies, Kits: ELISA Kits, Kits CLIA and All Kits and Reagents: Proteins, Peptides, Lysates, Isotype Controls and Accessory Reagents. The firm helps customers as a scientist to find the right products and search in its database, compare similar products online or consult its technical hotline and order directly with them. The company was founded by Andreas Kessell, Florian Heinemann, Tim Hiddemann in 2006 and is headquartered in Aachen, Germany.

Institute For Research In Biomedicine is a Swiss private company located in Bellinzona that provides biomedicine research and development services.\nThe company says this about itself: Founded in 2000 in Bellinzona, the IRB is affiliated with the Università della Svizzera italiana, since 2010. IRB hosts 13 research groups studying defense mechanisms to fight infections, tumors and degenerative diseases. With more than 630 publications in main scientific journals, the IRB has gained international recognition as a center of excellence for immunology and cell biology. Molinari’s laboratory investigates the protein quality control processes determining whether a polypeptide should be secreted, retained in the ER, or selected for degradation. Particular emphasis is given to the study of select rare diseases such as a1-antitrypsin deficiency, LSDs and Charcot-Marie-Tooth 1B neuropathy.

Anhui Yunyan Food Technology Co., Ltd., established on 2016-12-07, Business scope includes licensed projects:food production;food sales;Food Internet Sales;Food import and export;Technology Import and Export;Import and export(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)General project:food sales(Only sell prepackaged food);production of agricultural products,Sales,processing,transportation,Storage and other related services;Sales of packaging materials and products;Corporate Image Planning;marketing planning;Business Management Consulting;Non-residential real estate leases;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion(Except for licensed business,Can independently operate projects that are not prohibited or restricted by laws and regulations)

Hangzhou Emerox Medical Technology Co., Ltd., established on 2016-12-28, Business scope includes general items:Production of Class I Medical Devices;data processing services;software development;software sales;Information Technology Consulting Services;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Engineering and Technology Research and Experimental Development;Special Equipment Repair;Machinery and Equipment Leasing;Health Consulting Services(Does not include medical services);Sales of Class I Medical Devices;Sales of Class II Medical Devices;Wholesale of computer software, hardware and auxiliary equipment;Instrument sales;Chemical product sales(No licensed chemical products);Specialty Chemicals Sales(Free of Hazardous Chemicals);Office Equipment Sales;Glassware Sales;Sales of plastic products;Import and export;Technology Import and Export(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).licensed items:Production of Class II Medical Devices;Production of Class III Medical Devices;Class III medical device business(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results).

CAVΛDIS™ is a Dutch biomedical company active in the field of cardiovascular risk assessment. They develop prognostic tests to identify patients at risk of cardiovascular and disease. The company identified several novel biomarkers predictive for cardiovascular events. It is their goal is to develop clinically meaningful risk stratification tools that will help personalize treatment and achieve better patient outcomes.

The Board of Trustees of the University of Illinois, part of University of Illinois, is a company headquartered in Urbana, IL, that trusts Except Educational Religious.

Wuhan Baiqi Biotechnology Co., Ltd., established on 2018-08-10, Business scope includes technology development in the field of biotechnology,technology transfer,technical consulting;laboratory reagent(Does not contain dangerous goods,medicine)research and development,Production,Wholesale and retail;Wholesale and retail of instruments and meters;Business Consulting(Does not include business surveys);Import and export,Technology Import and Export,Agent import and export(Does not contain goods or technologies that are prohibited or restricted from import and export by the state).(Projects subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Wuhan Woyi Biological Co., Ltd., established on 2012-03-06, Business scope includes licensed projects:Import and export;Technology Import and Export;Import and export agency(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Sales of Class I Medical Devices;Production of Class I Medical Devices;Sales of special instruments and meters for agriculture, forestry, animal husbandry and fishery;Manufacturing of special instruments and meters for agriculture, forestry, animal husbandry and fishery;Specialty Chemicals Sales(Free of Hazardous Chemicals);Retailing of computer software, hardware and auxiliary equipment;Wholesale of computer software, hardware and auxiliary equipment;Optical communication equipment sales;Manufacturing of Optical Communication Equipment;Communication equipment manufacturing;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Optical Instrument Sales;Optical Instrument Manufacturing(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)